AlgenScribe
PrivateLast Round
Seed
Nov 22, 2025
Total Funding Raised
$541,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AlgenScribe operates in Healthcare & Life Sciences and is based in Nice. Its latest recorded funding round was a Seed round in November 2025.
AlgenScribe is a biotechnology company developing a genome editing platform to improve human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgenScribe Comparables
Compare AlgenScribe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integra Therapeutics | 81% | |
| Caszyme | 74% | |
| Mammoth Biosciences | 73% |
For institutional investors. Book with your work email.
AlgenScribe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 22, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Pre Seed | Jun 5, 2023 |
For institutional investors. Book with your work email.
AlgenScribe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 590% MoM, from 73 to 504.
- Nov 22, 2025
$541K raised in Seed round.
For institutional investors. Book with your work email.
AlgenScribe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlgenScribe's valuation, stock price, and market status.
Is AlgenScribe a public or private company?
AlgenScribe is a private company.
What is the current stock price of AlgenScribe?
AlgenScribe is a private company, so its shares have no public market price. Caplight tracks AlgenScribe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlgenScribe worth (valuation)?
Valuation information for AlgenScribe is not publicly available.
Can I buy AlgenScribe stock?
AlgenScribe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlgenScribe's last funding round?
AlgenScribe's most recent funding round was Seed on November 22, 2025.
Who are the main investors in AlgenScribe?
Key investors in AlgenScribe include Agence Nationale de la Recherche.
Will AlgenScribe IPO soon?
No public IPO plans have been announced for AlgenScribe.
How can I track AlgenScribe secondary market activity?
Caplight tracks bids, offers, and trades in AlgenScribe's shares on secondary markets.